Bicara therapeutics to present at the goldman sachs 46th annual global healthcare conference

Boston, june 03, 2025 (globe newswire) -- bicara therapeutics inc. (nasdaq: bcax), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that members of management will participate in a fireside chat at the goldman sachs 46th annual global healthcare conference on tuesday, june 10, 2025 at 3:20 p.m. et.
BCAX Ratings Summary
BCAX Quant Ranking